Status:
COMPLETED
Ovarian Response Prediction in In Vitro Fertilization (IVF) Patients
Lead Sponsor:
University Hospital Schleswig-Holstein
Conditions:
Infertility, Subfertility
Eligibility:
FEMALE
18-45 years
Brief Summary
The aim of the study is to explore ovarian response in terms of oocyte numbers after ovarian stimulation in a fixed gonadotropin dose GnRH-antagonist protocol by endocrine (AMH, FSH), demographic (age...
Detailed Description
Assisted reproduction by in-vitro fertilisation plays a pivotal role in the treatment of infertility, the understanding of reproductive biology, and future population dynamics. The success of assisted...
Eligibility Criteria
Inclusion
- Female patients for who the treating physician decides that treatment with long acting FSH 150µg in a GnRH-antagonist protocol is indicated.
Exclusion
- Contraindications for the use of gonadotropins (e.g., tumors, pregnancy/lactation, undiagnosed vaginal bleeding, hypersensitivity, ovarian cysts) Use of hormonal preparations within one month prior to inclusion
Key Trial Info
Start Date :
September 1 2010
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
January 1 2014
Estimated Enrollment :
294 Patients enrolled
Trial Details
Trial ID
NCT01206803
Start Date
September 1 2010
End Date
January 1 2014
Last Update
January 5 2016
Active Locations (5)
Enter a location and click search to find clinical trials sorted by distance.
1
Fertility Center Kiel
Kiel, S-H, Germany, 24103
2
University Hospital of Schleswig-Holstein, Campus Luebeck
Lübeck, Schleswig-Holstein, Germany, 23538
3
Prof. Axel Kamischke
Münster, Germany, 48143
4
Sabine Segerer
Würzburg, Germany, 97080